Literature DB >> 32106296

Incidence, mechanisms, and clinical impact of inappropriate shocks in patients with a subcutaneous defibrillator.

Boris Rudic1,2, Erol Tülümen1,2, Fabian Fastenrath1,2, Susanne Röger1,2, Diana Goranova1,2, Ibrahim Akin1,2, Martin Borggrefe1,2, Jürgen Kuschyk1,2.   

Abstract

AIMS: Inappropriate shocks (IAS) remain a challenge for patients and physicians after implantation of the subcutaneous implantable cardioverter-defibrillator (S-ICD). The aims were to assess and characterize different patterns of IAS. METHODS AND
RESULTS: Two hundred and thirty-nine patients were implanted with an S-ICD between 2010 and 2018 for primary and secondary prevention. Follow-up data of at least 6 months were analysed. During a mean follow-up of 34.9 ± 16.0 months, a total of 73 shocks occurred in 38 patients (6%). Forty-three (59%) shocks were considered appropriate due to ventricular tachycardia/ventricular fibrillation, while 30 (41%) were inappropriate and occurred in 19 patients (8%). Myopotentials/noise was the most frequent cause of inappropriate shocks (n = 8), followed by T-wave oversensing (n = 6) and undersensing of the QRS, resulting in adaptation of the automatic gain control and inappropriate shock (n = 5). Seventy-four percent of all IAS occurred on the primary vector, while no IAS occurred on the alternate vector. In seven of eight patients (88%), IAS related to myopotentials have occurred on the primary sensing vector. Multivariate analysis identified taller patients, primary sensing vector and first-generation S-ICD device as predictors for IAS. SMART pass effectively reduced the occurrence of IAS in the second-generation S-ICD system.
CONCLUSION: Inappropriate therapies are less frequently observed on the alternate vector. The primary vector seems to be unfavourable with regard to oversensing caused by myopotentials. Inappropriate shocks were associated with an increased rate of rehospitalization but not mortality. These observations have implications for the prevention of inappropriate S-ICD shocks. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inappropriate shock; Programming; Sensing vector; Subcutaneous implantable cardioverter-defibrillator; Ventricular tachyarrhythmias

Mesh:

Year:  2020        PMID: 32106296     DOI: 10.1093/europace/euaa026

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  A real-world experience of subcutaneous and transvenous implantable cardiac defibrillators-comparison with the PRAETORIAN study.

Authors:  Dibbendhu Khanra; Abdul Hamid; Peysh Patel; John Tomson; Ahmed Abdalla; Nasrin Khan; Rory Dowd; Nakul Chandan; Christopher Osagie; Tomilola Jinadu; Selvakumar Velu; Anita Arya; Charles Spencer; Craig Barr; Sanjiv Petkar
Journal:  J Arrhythm       Date:  2022-02-21

2.  A novel use of a subcutaneous implantable cardioverter-defibrillator algorithm to detect bradycardia.

Authors:  Timothy M Markman; Joseph Brozoski; Weeranun Bode; Saman Nazarian
Journal:  HeartRhythm Case Rep       Date:  2021-11-27

3.  Sudden depression of R-wave amplitude in a patient who underwent subcutaneous implantable cardioverter-defibrillator implantation.

Authors:  Masaki Takahashi; Hidekazu Kondo; Tetsuji Shinohara; Naohiko Takahashi
Journal:  HeartRhythm Case Rep       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.